
Estela Rodriguez/X
Apr 15, 2025, 07:40
Estela Rodriguez: The second-line options for EGFR lung cancer beyond platinum-chemo after best therapies upfront
Estela Rodriguez, Associate Director, Community Outreach of Thoracic Oncology at Sylvester Comprehensive Cancer Center , shared a post on X:
“If we move our best therapies upfront, what are the 2nd line options for EGFR lung cancer beyond platinum-chemo?
- amivantamab+chemo
- ivonescimab+chemo
- ADCs: DatoDxd, PatritumabDxd.”
More posts featuring TexasLung25.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 15, 2025, 07:23
Apr 15, 2025, 07:10
Apr 15, 2025, 07:04
Apr 15, 2025, 04:10
Apr 14, 2025, 19:10